RxDoctor Payments Data

Shaina Lipa, MD

Orthopaedic Surgery · Boston, MANPI 1598178444

Payments from drug & device makers

$60,794in general payments, 2019–2025

Across 165 payments — averaging $368.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$51K
  • Globus Medical$4K
  • Depuy Synthes Products, Inc.$3K
  • Alphatec Spine, Inc$2K
  • Stryker$476
  • Zimmer Biomet$237
  • plus $201 from 2 others

What the payments were for

  • Consulting fees$20,33033%
  • Speaking & faculty fees$20,94034%
  • Travel & lodging$13,28322%
  • Food & beverage$6,24110%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)115$51,317
Globus Medical(2 entities)36$3,605
Depuy Synthes Products, Inc.1$3,390
Alphatec Spine, Inc3$1,568
Stryker3$476
Zimmer Biomet2$237
Johnson & Johnson4$185
Bioventus LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,794 in reported general payments places this provider in the 85th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$35,359
Medicare patients
94
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl15$123
Tizanidine Hcl14$65
Meloxicam14$12

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →